MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2024 International Congress

    Shifting Paradigms In Huntington’s Disease Research: A Five-Year Scopus-Based Bibliometric Exploration

    RN. Surbakti, RK. Praja (Palangka Raya, Indonesia)

    Objective: This study aimed to investigate the shifting trends (2019-2024) in research on Huntington's disease (HD)based on bibliometric lens. Background: Huntington's disease is a movement…
  • 2024 International Congress

    Deep Brain Stimulation for Post-Hypoxic Myoclonus: A Case Correlating Local Field Potentials to Clinical Outcome

    H. Kaur, T. Goble, A. Fenoy, R. Ramdhani (Great neck, USA)

    Objective: To correlate local filed potential (LFP) spectral data with clinical improvement of the Unified Myoclonus Rating Scale (UMRS) in post-hypoxic myoclonus (PHM) syndrome treated…
  • 2024 International Congress

    The Spectrum of Presenting Phenotypes in Childhood Onset Huntingtons Disease

    K. Yang, V. Quiroz, A. Tam, X. Villanueva, C. Amarales, D. Ebrahimi-Fakhari (Boston, USA)

    Objective: ​​​​​​Childhood-onset Huntington’s disease (HD) is a rare subset of HD with symptom-onset before the age of 18 years. We here detail the presenting movement…
  • 2024 International Congress

    ​​Deciphering the Huntington’s Disease Research Landscape: A Comprehensive Bibliometric and Trend Analysis

    S. Khankar, T. Lalotra, A. Subhedar, S. Joshi, S. Mast, A. Bhonsale (Nagpur, India)

    Objective: To map the Huntington's Disease research landscape, identifying key trends, gaps, and the most impactful studies to guide future research directions and therapeutic strategies.…
  • 2024 International Congress

    Clinical and Epidemiological Aspects of Neuropsychiatric Features in Patients with Huntington Disease in Chile

    J. Fuentes, P. Salles, P. Chaná-Cuevas, C. Montalva, M. Sánchez, N. Rojas (Santiago, Chile)

    Objective: To describe the prevalence of motor and neuropsychiatric symptoms in HD patients seen at the Center of Movement Disorders (CETRAM), Santiago, Chile. Background: There…
  • 2024 International Congress

    Physical Activity Levels and Demographic Characteristics in Individuals with Huntington’s Disease: Insights from the ENROLL-HD Database in an Argentinian Movement Disorder Center

    M. Espindola, N. Gonzalez Rojas, G. da Prat, M. Cesarini, G. Peker, J. Etcheverry, E. Gatto (Buenos Aires, Argentina)

    Objective: To assess PA levels in individuals enrolled in the ENROLL-HD database, and compare demographic characteristics between PE practitioners, and non-practitioners Background: Neurological disorders have been…
  • 2024 International Congress

    Recrudescence of a Compensated Hemidystonia-hemiatrophy Syndrome After COVID-19 Infection

    A. Kundrick, H. Fernandez (Cleveland, USA)

    Objective: To educate readers about a unique presentation of hemidystonia-hemiatrophy syndrome which presented after an infection with COVID-19 Background: Hemidystonia-hemiatrophy syndrome is a rare disorder…
  • 2024 International Congress

    Phenotypic Aspects of Huntington’s Disease-Like 2 in Brazil and the World: Literature Review

    D. Boone, M. Costa, C. Silva, L. Barcelos, B. Veiga, R. Pinto, P. Aguiar, S. Azevedo, V. Borges, H. Ferraz (São Paulo, Brazil)

    Objective: To describe the known phenotypic profile of HDL2 patients currently described in the literature. Background: HDL2 is an autosomal dominant neurodegenerative disorder caused by…
  • 2024 International Congress

    Model-Based Gait Outcomes to Track Parkinson’s Disease Progression ?

    CE. Mvomo, J. Bedime, S. Perfetto, I. Sierra, H. Lajeunesse, A. Potvin-Desrochers, CA. Easthope, C. Paquette (Montreal, Canada)

    Objective: To determine whether outcomes extracted from a gait model can serve as markers of symptoms and neurodegeneration progression in Parkinson’s disease (PD). Background: Longitudinal…
  • 2024 International Congress

    Value of DaTSPECT in rare movement disorders: neurodegenerative diseases

    E. Ardila Jurado, L. Zünd-Hofer, F. Brugger, G. Kägi (St Gallen, Switzerland)

    Objective: To explore the expanding indications of dopamine transporter imaging (DaT Spect) beyond the established indications. Background: DaTSPECT is a well-established method to rule out…
  • « Previous Page
  • 1
  • …
  • 474
  • 475
  • 476
  • 477
  • 478
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley